AMF Anticancer composition comprising prostate cancer cell line-derived autocrine motility factor as effective component

摘要

The present invention relates to a composition for anticancer containing a prostate cancer cell line-derived AMF as an active component. More specifically, the prostate cancer cell line-derived AMF of the present invention has an excellent effect of inhibiting the proliferation of pancreatic cancer, leukemic cancer, and brain cancer, and causing cell death. Therefore, the composition containing the prostate cancer cell line-derived AMF of the present invention can be used as an anticancer therapeutic agent.